Abstract Background Chronic hepatitis B (CHB) and fatty liver (FL) are common, natural
history data on concurrent FL and CHB (FL-CHB) are limited. This study aimed to evaluate …

Methods We searched 4 databases from inception to December 2021 and pooled study-
level estimates using a random-effects model for conventional MA. For IPDMA, we evaluated …

Background & aims Nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis B (CHB)
are common liver diseases. Concurrent NAFLD may affect antiviral treatment outcomes in …

Abstract Objective Chronic hepatitis B (CHB) and metabolic dysfunction-associated fatty liver
disease (MAFLD) are the leading causes of hepatocellular carcinoma (HCC). We aim to …

Hepatitis B virus (HBV) infection and nonalcoholic fatty liver disease (NAFLD) are two major
causes of chronic liver disease (CLD) that can cause liver cirrhosis and hepatocellular …

Background Concomitant chronic hepatitis B infection (CHB) and non-alcoholic fatty liver
disease (NAFLD) is common, but the implications of NAFLD on clinical outcomes of CHB …

Abstract Background and Aims Concurrent fatty liver in hepatitis B virus (HBV)‐infected
patients without significant alcohol intake is a frequent and increasingly alarming problem …

Methods Consecutive CHB patients who underwent liver biopsy from January 2007 to
December 2015 were included. The association between hepatic steatosis (≥ 5%) and …

Background The association between metabolic dysfunction‐associated fatty liver disease
(MAFLD) and hepatocellular carcinoma (HCC) lacks clinical validation in at‐risk …

Background We aimed to explore the impact of hepatitis B virus (HBV) infection on the
prevalence of nonalcoholic fatty liver disease (NAFLD) based on clinical big data. Methods …